178 related articles for article (PubMed ID: 28843812)
1. Resistance of human plasmacytoid dendritic CAL-1 cells to infection with lymphocytic choriomeningitis virus (LCMV) is caused by restricted virus cell entry, which is overcome by contact of CAL-1 cells with LCMV-infected cells.
Iwasaki M; Sharma SM; Marro BS; de la Torre JC
Virology; 2017 Nov; 511():106-113. PubMed ID: 28843812
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
[TBL] [Abstract][Full Text] [Related]
3. Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes.
Iwasaki M; Urata S; Cho Y; Ngo N; de la Torre JC
Virology; 2014 Jun; 458-459():22-32. PubMed ID: 24928036
[TBL] [Abstract][Full Text] [Related]
4. Plasmacytoid dendritic cells are productively infected and activated through TLR-7 early after arenavirus infection.
Macal M; Lewis GM; Kunz S; Flavell R; Harker JA; Zúñiga EI
Cell Host Microbe; 2012 Jun; 11(6):617-30. PubMed ID: 22704622
[TBL] [Abstract][Full Text] [Related]
5. Human plasmacytoid dendritic cells sense lymphocytic choriomeningitis virus-infected cells in vitro.
Wieland SF; Takahashi K; Boyd B; Whitten-Bauer C; Ngo N; de la Torre JC; Chisari FV
J Virol; 2014 Jan; 88(1):752-7. PubMed ID: 24155390
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic and Apathogenic Strains of Lymphocytic Choriomeningitis Virus Have Distinct Entry and Innate Immune Activation Pathways.
Johnson DM; Khakhum N; Wang M; Warner NL; Jokinen JD; Comer JE; Lukashevich IS
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675975
[TBL] [Abstract][Full Text] [Related]
7. Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.
Ngo N; Henthorn KS; Cisneros MI; Cubitt B; Iwasaki M; de la Torre JC; Lama J
J Virol; 2015 Nov; 89(21):10924-33. PubMed ID: 26292327
[TBL] [Abstract][Full Text] [Related]
8. Genome-Wide Knockout Screen Identifies Human Sialomucin CD164 as an Essential Entry Factor for Lymphocytic Choriomeningitis Virus.
Liu J; Knopp KA; Rackaityte E; Wang CY; Laurie MT; Sunshine S; Puschnik AS; DeRisi JL
mBio; 2022 Jun; 13(3):e0020522. PubMed ID: 35502904
[TBL] [Abstract][Full Text] [Related]
9. Lymphocytic choriomeningitis arenavirus requires cellular COPI and AP-4 complexes for efficient virion production.
Byford O; Shaw AB; Tse HN; Todd EJAA; Álvarez-Rodríguez B; Hewson R; Fontana J; Barr JN
J Virol; 2024 Mar; 98(3):e0200623. PubMed ID: 38334330
[TBL] [Abstract][Full Text] [Related]
10. Virus-specific MHC-class II-restricted TCR-transgenic mice: effects on humoral and cellular immune responses after viral infection.
Oxenius A; Bachmann MF; Zinkernagel RM; Hengartner H
Eur J Immunol; 1998 Jan; 28(1):390-400. PubMed ID: 9485218
[TBL] [Abstract][Full Text] [Related]
11. Anti-GITR agonist therapy intrinsically enhances CD8 T cell responses to chronic lymphocytic choriomeningitis virus (LCMV), thereby circumventing LCMV-induced downregulation of costimulatory GITR ligand on APC.
Clouthier DL; Zhou AC; Watts TH
J Immunol; 2014 Nov; 193(10):5033-43. PubMed ID: 25281716
[TBL] [Abstract][Full Text] [Related]
12. Multiple mechanisms contribute to impairment of type 1 interferon production during chronic lymphocytic choriomeningitis virus infection of mice.
Lee LN; Burke S; Montoya M; Borrow P
J Immunol; 2009 Jun; 182(11):7178-89. PubMed ID: 19454715
[TBL] [Abstract][Full Text] [Related]
13. Persistent infection of some standard cell lines by lymphocytic choriomeningitis virus: transmission of infection by an intracellular agent.
van der Zeijst BA; Noyes BE; Mirault ME; Parker B; Osterhaus AD; Swyryd EA; Bleumink N; Horzinek MC; Stark GR
J Virol; 1983 Oct; 48(1):249-61. PubMed ID: 6193287
[TBL] [Abstract][Full Text] [Related]
14. Cellular entry of lymphocytic choriomeningitis virus.
Rojek JM; Perez M; Kunz S
J Virol; 2008 Feb; 82(3):1505-17. PubMed ID: 18045945
[TBL] [Abstract][Full Text] [Related]
15. An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus.
Roost H; Charan S; Gobet R; Rüedi E; Hengartner H; Althage A; Zinkernagel RM
Eur J Immunol; 1988 Apr; 18(4):511-8. PubMed ID: 2452742
[TBL] [Abstract][Full Text] [Related]
16. CD164 is a host factor for lymphocytic choriomeningitis virus entry.
Bakkers MJG; Moon-Walker A; Herlo R; Brusic V; Stubbs SH; Hastie KM; Saphire EO; Kirchhausen TL; Whelan SPJ
Proc Natl Acad Sci U S A; 2022 Mar; 119(10):e2119676119. PubMed ID: 35235462
[TBL] [Abstract][Full Text] [Related]
17. Functional limitations of plasmacytoid dendritic cells limit type I interferon, T cell responses and virus control in early life.
Belnoue E; Fontannaz P; Rochat AF; Tougne C; Bergthaler A; Lambert PH; Pinschewer DD; Siegrist CA
PLoS One; 2013; 8(12):e85302. PubMed ID: 24376875
[TBL] [Abstract][Full Text] [Related]
18. Lymphocytic choriomeningitis virus mx strain does not induce the expression of tumor-associated carbonic anhydrase IX in persistently infected HeLa cells.
Labudová M; Tomásková J; Kaluzová M; Pastorek J; Pastoreková S
Acta Virol; 2006; 50(1):53-8. PubMed ID: 16599186
[TBL] [Abstract][Full Text] [Related]
19. A role for the transcription factor RelB in IFN-alpha production and in IFN-alpha-stimulated cross-priming.
Le Bon A; Montoya M; Edwards MJ; Thompson C; Burke SA; Ashton M; Lo D; Tough DF; Borrow P
Eur J Immunol; 2006 Aug; 36(8):2085-93. PubMed ID: 16810633
[TBL] [Abstract][Full Text] [Related]
20. Infection of dendritic cells by lymphocytic choriomeningitis virus.
Sevilla N; Kunz S; McGavern D; Oldstone MB
Curr Top Microbiol Immunol; 2003; 276():125-44. PubMed ID: 12797446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
